Close Menu

NEW YORK – Quest Diagnostics announced on Wednesday the acquisition of genetic testing firm Blueprint Genetics in a deal it said will "broaden access to actionable insights in genetic and rare diseases, improving patient care and pharmaceutical drug research and development."

Details of the all-cash transaction were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.